Experimental study of teicoplanin, alone and in combination, in the therapy of cephalosporin-resistant pneumococcal meningitis

Journal of Antimicrobial Chemotherapy

Volumn 55, Issue 1, 2005, Pages 78-83

  Fernandez A ^a   Cabellos, C ^a   Tubau, F ^a   Maiques, J M ^a   Domenech A ^a   Ribes, S ^a   Linares J ^a   Viladrich, P F ^a   Gudiol, F ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

Bacterial meningitis; Dexamethasone; Glycopeptides; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; LACTIC ACID; ORITAVANCIN; PENICILLIN G; PROTEIN; ROCEFALIN; TEICOPLANIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CEREBROSPINAL FLUID; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENTIATION; IN VITRO STUDY; INOCULATION; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; NONHUMAN; PHARMACODYNAMICS; PROTEIN BLOOD LEVEL; RABBIT;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CEFTRIAXONE; CEPHALOSPORIN RESISTANCE; COLONY COUNT, MICROBIAL; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; HUMANS; MENINGITIS, PNEUMOCOCCAL; MICROBIAL SENSITIVITY TESTS; RABBITS; STREPTOCOCCUS PNEUMONIAE; TEICOPLANIN;

EID: 13244259235     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh496     Document Type: Article

References (32)

1. Baquero, F., García-Rodríguez, J. A., García de Lomas, J. et al. (1999). Antimicrobial resistance of 1113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: results of a 1-year (1996-1997) multicentre surveillance study. Antimicrobial Agents and Chemotherapy 43, 357-9.
2. Doern, G. V., Heilmann, K. P., Huynh, H. K. et al. (2001). Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000, including a comparison of resistance rates since 1994-1995. Antimicrobial Agents and Chemotherapy 45, 1721-9.
3. Whitney, C. G., Farley, M. M., Hadler, J. et al. (2000). Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. New England Journal of Medicine 343, 1917-24.
4. Cottagnoud, P. H. & Tauber, M. G. (2004). New therapies for pneumococcal meningitis. Expert Opinion on Investigational Drugs 13, 393-401.
5. McMaster, P., McIntyre, P., Gilmour, R. et al. (2002). The emergence of resistant pneumococcal meningitis-implictions for empiric therapy. Archives of Disease in Childhood 87, 207-10.
6. Kaplan, S. L. & Mason, E. O. (1998). Management of infections due to antibiotic-resistant Streptococcus pneumoniae. Clinical Microbiology Reviews 11, 628-44.
7. Viladrich, P. F., Cabellos, C., Pallares, R. et al. (1996). High doses of cefotaxime in treatment of adult meningitis due to Streptococcus pneumoniae with decreased susceptibilities to broad-spectrum cephalosporins. Antimicrobial Agents and Chemotherapy 40, 218-20.
8. Bradley, J. S. & Connor, J. D. (1991). Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to β-lactam antibiotics. Pediatric Infectious Diseases Journal 10, 871-3.
9. Catalan, M. J., Fernandez, J. M., Vazquez, A. et al. (1994). Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clinical infectious Diseases 18, 766-9.
10. Viladrich, P. F., Gudiol, F., Liñares, J. et al. (1991). Evaluation of vancomycin for therapy of adult pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 35, 2467-72.
11. Ahmed, A., Jafri, H., Lutsar, I. et al. (1999). Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 43, 876-81.
12. Friedland, I. R., Paris, M., Ehrett, S. et al. (1993). Evaluation of antimicrobial regimens for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 37, 1630-6.
13. Tunkel, A. R. & Scheld, W. M. (2002). Treatment of bacterial meningitis. Current Infectious Disease Reports 4, 7-16.
14. Cabellos, C., Fernandez, A., Maiques, J. M. et al. (2003). Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 47, 1907-11.
15. Knudsen, J. D., Fuursted, K., Espersen, F. et al. (1997). Activities of vancomycin and teicoplanin against penicillin-resistant pneumococci in vitro and in vivo and correlation to pharmacokinetic parameters in the mouse peritonitis model. Antimicrobial Agents and Chemotherapy 41, 1910-5.
16. Knudsen, J. D., Fuursted, K., Raber, S. et al. (2000). Pharmacodynamics of glycopeptides in the mouse peritonitis model of Streptococcus pneumoniae or Staphylococcus aureus infection. Antimicrobial Agents and Chemotherapy 44, 1247-54.
17. Lazzarini, L., Tramarin, A., Bragagnolo, L. et al. (2002). Three-times weekly teicoplanin in the outpatient treatment of acute methicillin-resistant staphylococcal osteomyelitis: a pilot study. Journal of Chemotherapy 14, 71-5.
18. LeFrock, J. & Ristuccia, A. (1999). Teicoplanin in the treatment of bone and joint infections: an open study. Journal of Infection and Chemotherapy 5, 32-9.
19. Wood, M. J. (2000). Comparative safety of teicoplanin and vancomycin. Journal of Chemotherapy 5, 21-5.
20. Jourdan, C., Convert, J., Peloux, A. et al. (1996). Adequate intrathecal diffusion of teicoplanin after failure of vancomycin, administered in continuous infusion in three cases of shunt associated meningitis. Pathologie Biologie (Paris) 44, 389-92.
21. Kralinsky, K., Lako, J., Dluholucky, S. et al. (1999). Nosocomial staphylococcal meningitis in neonates successfully treated with intraventricular teicoplanin. Chemotherapy 45, 313-4.
22. Fanos, V. & Dall'Agnola, A. (1999). Antibiotics in neonatal infections: a review. Drugs 58, 405-27.
23. National Committee for Clinical Laboratory Standards. (2000). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically - Fifth Edition: Approved Standard M7-A5. NCCLS, Wayne, PA, USA.
24. Dacey, M. G. & Sande, M. A. (1974). Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivates. Antimicrobial Agents and Chemotherapy 57, 437-41.
25. Chambers, H. F. & Kennedy, S. (1990). Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis. Antimicrobial Agents and Chemotherapy 34, 510-4.
26. Cabellos, C., Martínez-Lacasa, J., Martos, A. et al. (1995). Influence of dexamethasone on efficacy of ceftriaxone and vancomycin therapy in experimental pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 39, 2158-60.
27. Chapin-Robertson, K. & Edberg, S. C. (1991). Measurement of antibiotics in human body fluids: techniques and significance. In Antibiotics in Laboratory Medicine (Lorian, V., Ed.), pp. 295-366. Williams and Wilkins, New York, NY, USA.
28. Knapp, C. & Moody, J. A. (1992). Test to assess bactericidal activity, sec 5.16 Clinical Microbiology Procedures Handbook (Isenberg, H. D., Ed.), p. 12. American Society for Microbiology, Washington, DC, USA, sec 5.16, sec 5.16.
29. Paris, M., Hickey, S. M., Usher, M. I. et al. (1994). Effect of dexamethasone on therapy of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis. Antimicrobial Agents and Chemotherapy 38, 1320-4.
30. Martínez-Lacasa, J., Cabellos, C., Martos, A. et al. (2002). Experimental study of the efficacy of vancomycin, rifampicin and dexamethasone in the therapy of pneumococcal meningitis. Journal of Antimicrobial Chemotherapy 49, 507-13.
31. Cruciani, M., Navarra, A., Di Perri, G. et al. (1992). Evaluation of intraventricular teicoplanin for the treatment of neurological shunt infections. Clinical Infectious Diseases 15 285-9.
32. Martin, C., Bourget, P., Alaya, M. et al. (1997). Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues. Antimicrobial Agents and Chemotherapy 41, 1150-5.